Trials / Completed
CompletedNCT02527187
Determination of the Sensitivity and Specificity of Prick Test Betula Verrucosa
Extract Allergen From Betula Verrucosa. Test Sensitivity and Specificity of Diagnostic in Prick Test Preparation.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 201 (actual)
- Sponsor
- Inmunotek S.L. · Industry
- Sex
- All
- Age
- 5 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is to evaluate the concentration of allergen extract of Betula verrucosa that elicit a papule equivalent to that produced by a solution of histamine dihydrochloride 10 mg / ml in size.
Detailed description
Open, prospective, unblinded and non-randomized biological assay. Each patient was tested with four concentrations of allergen and with a histamine and saline solution as positive and negative controls, respectively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 10 HEP/mL Betula verrucosa allergen extract | The investigational product contained 10 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique. |
| BIOLOGICAL | 25 HEP/mL Betula verrucosa allergen extract | The investigational product contained 25 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique. |
| BIOLOGICAL | 50 HEP/mL Betula verrucosa allergen extract | The investigational product contained 50 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique. |
| BIOLOGICAL | 100 HEP/mL Betula verrucosa allergen extract | The investigational product contained 100 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-04-01
- Completion
- 2016-11-01
- First posted
- 2015-08-18
- Last updated
- 2022-05-05
- Results posted
- 2022-05-05
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02527187. Inclusion in this directory is not an endorsement.